Home > Clinical Trials
Check All Search

Saved trials

SUSPENDED
NCT04616560
Trastuzumab Deruxtecan for the Treatment of HER2+ Newly Diagnosed or Recurrent Osteosarcoma
77 Enrollment(s)
28 Study location(s)
INTERVENTIONAL (PHASE2)
Osteosarcoma


Recurrent Osteosarcoma
RECRUITING
NCT04585958
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
55 Enrollment(s)
5 Study location(s)
INTERVENTIONAL (PHASE1)
Metastatic Malignant Solid Neoplasm


Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma


Unresectable Malignant Solid Neoplasm
ACTIVE_NOT_RECRUITING
NCT03742102
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
243 Enrollment(s)
32 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Triple Negative Breast Neoplasms
RECRUITING
NCT07060807
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
1,000 Enrollment(s)
115 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Neoplasms
NOT_YET_RECRUITING
NCT07371585
Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
300 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer Stage IV
NOT_YET_RECRUITING
NCT07368543
Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer
216 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Metastatic Breast Cancer
RECRUITING
NCT06912763
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
250 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Fibrosis Syndrome


Lymphedema


Head &Amp; Neck Cancer


Fibrosis
RECRUITING
NCT07307170
The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
750 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Herpes Zoster


Mirogabalin


Pain